Stay updated on Depemokimab Clinical Trial in Severe Eosinophilic Asthma
Sign up to get notified when there's something new on the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page.

Latest updates to the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page
- Check4 days agoChange DetectedThe study record for the completed Phase 3 depemokimab asthma trial is now available, including its design, eligibility criteria, locations, outcome measures, publications, and study documents.SummaryDifference97%

- Check11 days agoChange DetectedThe footer’s displayed site revision changed from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoChange DetectedA site-wide banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check25 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2; the page continues to display a 403 error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe site revision in the footer changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the expected study record content, indicating that access to the study details is blocked.SummaryDifference17%

Stay in the know with updates to Depemokimab Clinical Trial in Severe Eosinophilic Asthma
Enter your email address, and we'll notify you when there's something new on the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page.